Curie-Cancer and Servier continue a renewed partnership in cancer research

Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have renewed their partnership with the aim of identifying therapeutic targets for treating so-called ‘triple negative’ breast cancers.



GLOBAL CARE is an outstanding consortium of 5 French expertises :